Germantown, MD (March 22, 2019). 3i Diagnostics, an innovator in developing novel diagnostics for identifying pathogens from blood directly without culturing announced that its CEO, James Janicki, was invited to present at the Longitude Prize Workshop. The workshop was held in Boston on March 21, 2019.
The workshop was intended to disseminate information about the Longitude Prize and hear about the latest cutting-edge technologies that might provide a solution to the Antimicrobial Crisis.
At the workshop, Mr. Janicki described the technology that 3i has been developing and the data demonstrating its feasibility. “Our Biospectrix platform technology is especially well suited to be accessible in all countries and as a point-of-care device because it does not require refrigeration; it is easily miniaturized; and the components are of materials that will result in exponential cost reduction as manufacturing volume Increases," said Jim Janicki
The Longitude Prize is an inducement prize contest offered by Nesta, a British lottery funded charity, in the spirit of the 18th-century Longitude rewards. It runs a £10 million prize fund, offering an £8 million payout to the team of researchers that develops an affordable, accurate, and fast point of care test for bacterial infection
In order to tackle growing levels of antimicrobial resistance, the challenge set for the Longitude Prize is to invent an affordable, accurate, fast and easy-to-use test for bacterial infections that will allow health professionals worldwide to administer the right antibiotics at the right time.
